Indication
Prevention of surgery-induced bleed in Von Willebrand's disease
Prevention of surgery-induced bleed in Von Willebrand's disease refers to the perioperative management aimed at mitigating excessive intraoperative and postoperative hemorrhagic complications in individuals with Von Willebrand disease undergoing elective or emergency surgical procedures. Read more about Prevention of surgery-induced bleed in Von Willebrand's disease
9 drugs 7 manufacturers
Drugs that treat it
Common Prevention of surgery-induced bleed in Von Willebrand's disease therapies.
WILATE (antihemophilic factor, human/von Willebrand factor,human)
VONVENDI (von Willebrand factor (recombinant))
VONVENDI (von Willebrand factor (recombinant))
HUMATE-P (antihemophilic factor, human/von Willebrand factor,human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of surgery-induced bleed in Von Willebrand's disease refers to the perioperative management aimed at mitigating excessive intraoperative and postoperative hemorrhagic complications in individuals with Von Willebrand disease undergoing elective or emergency surgical procedures.
Von Willebrand disease is the most common inherited hematologic bleeding disorder, characterized by a quantitative deficiency or qualitative defect in von Willebrand factor (VWF).
This defect impairs platelet adhesion to the damaged vascular subendothelium during primary hemostasis and can lead to secondary factor VIII deficiency due to reduced plasma carrier stabilization, predisposing patients to prolonged mucosal, soft tissue, and surgical-site hemorrhage.
- fda.gov
Prevention of surgery-induced bleed in Von Willebrand's disease refers to the perioperative management aimed at mitigating excessive intraoperative and postoperative hemorrhagic complications in individuals with Von Willebrand disease undergoing elective or emergency surgical procedures
- nih.gov
Prevention of surgery-induced bleed in Von Willebrand's disease refers to the perioperative management aimed at mitigating excessive intraoperative and postoperative hemorrhagic complications in individuals with Von Willebrand disease undergoing elective or emergency surgical procedures This defect impairs platelet adhesion to the damaged vascular subendothelium during primary hemostasis and can lead to secondary factor VIII deficiency due to reduced plasma carrier stabilization, predisposing pa...
- takeda.com
Von Willebrand disease is the most common inherited hematologic bleeding disorder, characterized by a quantitative deficiency or qualitative defect in von Willebrand factor (VWF)
- nih.gov
Von Willebrand disease is the most common inherited hematologic bleeding disorder, characterized by a quantitative deficiency or qualitative defect in von Willebrand factor (VWF)
- fda.gov
This defect impairs platelet adhesion to the damaged vascular subendothelium during primary hemostasis and can lead to secondary factor VIII deficiency due to reduced plasma carrier stabilization, predisposing patients to prolonged mucosal, soft tissue, and surgical-site hemorrhage
Personalize your experience
Follow Prevention of surgery-induced bleed in Von Willebrand's disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.